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 Abstract 
Hyperthermia is an environmental stressor that produces marked increases in visceral 
sympathetic nerve discharge (SND) in young rats.  The brainstem in rats contains the essential 
neural circuitry for mediating visceral sympathetic activation; however, specific brainstem sites 
involved remain virtually unknown.  The rostral ventral lateral medulla (RVLM) is a key central 
nervous system region involved in the maintenance of basal SND and in mediating sympathetic 
nerve responses evoked from supraspinal sites.  In the present study we tested the hypothesis that 
inhibition of RVLM synaptic activation at peak hyperthermia (internal body temperature, Tc, 
increased to 41.5°C) would affect heating-induced visceral sympathetic activation.  Experiments 
were completed in chloralose-urethane anesthetized, baroreceptor-intact and sinoaortic-
denervated, 3-6 month-old Sprague-Dawley rats.  Bilateral inhibition of RVLM synaptic 
activation produced by muscimol microinjections (400 and 800 pmol) at 41.5°C resulted in 
immediate and significant reductions in peak heating-induced renal and splenic 
sympathoexcitation.  Interruption of RVLM synaptic activation and axonal transmission by 
lidocaine microinjections (40 nmol) at 41.5°C produced significant reductions in hyperthermia-
induced sympathetic activation to similar levels produced by RVLM muscimol microinjections.   
The total amount of SND inhibited by RVLM muscimol and lidocaine microinjections was 
significantly more during hyperthermia (41.5°C) than normothermia (38°C).  These findings 
demonstrate that maintenance of sympathetic activation at peak hyperthermia is dependent on the 
integrity of RVLM neural circuits. 
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Introduction 
The sympathetic nervous system (SNS) plays a critical role in the maintenance of 
physiological homeostasis under basal conditions as well as in response to acute and chronic 
stressors.  Specifically, it is important to understand that the SNS is not a turn it on, turn it off 
system as previously thought.  The background level of sympathetic nerve discharge (SND) in 
nerves innervating the heart, blood vessels and visceral organs are tonically active and are 
characterized by the presence of synchronized discharge bursts (Kenney et al., 1995; Kenney et 
al., 1998; Kenney and Fels, 2002; Kenney and Fels, 2003).  It is because of this background 
Figure 1-1 Original tracing recorded from renal sympathetic nerve during an experiment 
 
 
 
 
 
 
level of sympathetic vasomotor activity (sympathetic tone) that allows central neural 
mechanisms to be either withdrawn or enhanced for short and long term BP stabilization in 
response to various challenges.   
Hyperthermia is an important and threatening environmental stressor.  In fact, heat 
related pathophysiological complications are thought to be one of the most prevalent killers in 
the world (Bouchama et al., 2007, Rey et al., 2007, Sharma, 2005; Sharma, 2007).  Heat stroke is 
characterized by hypotension, SNS dysregulation and reduced cerebral blood flow (Huang et al., 
2005, Li et al., 2001).  Consequently, with the frequency and intensity of heat waves throughout 
the world are on the rise and climate models predicting an even higher incidence of severe heat 
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waves (Barbieri et al., 2006, Brown et al., 2007, Conti et al., 2007, Davis et al., 2003, Diaz et al., 
2006, Empereur-Bissonnet et al., 2006, Garssen et al., 2005, Hajat et al., 2007, Keatinge and 
Donaldson, 2004, Michelozzi et al., 2005, Naughton et al., 2002, Sharma, 2005, Simon et al., 
2005, Tan et al. 2007, Weisskopf et al., 2002), studying and understanding SND responses to 
hyperthermia is imperative; particularly when considering the robust and reproducible effects 
that acute heat stress has on the level of efferent SND.  For example, acute elevations in internal 
body temperature (Tc) decrease SND directed to the caudal ventral artery in anesthetized rats 
Figure 1-2 Original records of muscle SND from human and renal SND from rat at            
normothermia (left) and during acute heating (right)                       
 
 
           
                  Crandall et al., 1999 
 
 
 
 (Johnson and Gilbey, 1994), increase muscle SND in conscious humans (Crandall et al., 1999; 
Niimi et al., 1997), splanchnic SND in conscious rats (Kregel et al., 1994), and renal, splanchnic, 
adrenal, and splenic SND in anesthetized rats (Kenney et al., 1995; Kenney et al., 1998; Kenney 
and Fels, 2002; Kenney and Fels, 2003).  Sympathoexcitatory responses as well as increases in 
mean arterial pressure (MAP) and HR occur in a progressive manner in response to increases in 
Tc.  These simultaneous changes suggest that sympathetic activation plays a critical role in 
Figure 1-3 Sympathetic and Cardiovascular responses to acute heat stress 
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mediating the cardiovascular responses needed to counteract the vasodilatory effects of acute 
heating.  Hyperthermia also alters the SND bursting pattern, transforming high-frequency, 
cardiac-related SND bursts in baroreceptor-innervated rats to a pattern that contains 
low-frequency, high-amplitude bursts (Kenney et al., 1998).  Pattern transformation plays an 
important role in the sympathoexcitatory responses to heat stress as the low-frequency SND 
bursts contain significantly more power than their high frequency counterparts (Kenney et al., 
1998).  The functional role of heating-induced alterations in SND regulation is supported by at 
Figure 1-4 Change in SND bursting pattern as Tc increases from 38°C to 41.5°C 
 
 
  
 
 
least three findings.  First, surgical ablation of the celiac ganglion increases the rate of heating 
and reduces heat tolerance time during hyperthermia in anesthetized rats (Kregel and Gisolfi, 
1989), demonstrating the importance of an intact visceral sympathetic innervation for thermal 
tolerance (Kregel and Gisolfi, 1989).  Second, as previously stated, heating-induced SND pattern 
changes contribute to the sympathoexcitation as low-frequency SND bursts contain significantly 
more power than their high-frequency, cardiac-related counterparts (Kenney et al., 1998).  Third, 
heating-induced sympathoexcitatory responses play a critical role in mediating cardiovascular 
responses.  Specifically, pharmacological blockade of autonomic ganglionic transmission during 
acute elevations in Tc reduces arterial blood pressure to values less than those produced by 
ganglionic blockade at normothermia (Kenney et al., 1998), indicating an important role for 
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sympathetic activation in maintaining arterial blood pressure while providing increased blood 
flow distribution for heat dissipation.    
Forebrain neural circuits, including the preoptic anterior hypothalamic area, are known to 
be important thermointegrative centers of the central nervous system (Gordon and Heath, 1986; 
Hammel, 1968; Hellon, 1970).  However, visceral SND responses to acute heating are similar in 
midbrain-transected and sham midbrain-transected rats (Kenney et al., 2000), and the full 
Figure 1-5 SND responses to heating after sham-midbrain (top) and midbrain (bottom) 
transection 
 
 
 
 
 
 
 
expression of SND responses to acute heating is not evident in cervical spinal cord-transected 
rats (Kenney et al., 2000).  Combined, these results indicate that heating-induced activation of 
Figure 1-6 SND responses to heating after cervical transection  
 
 
 
 
visceral SND is not dependent on intact neural connections between forebrain and brainstem 
neural circuits and that the rat brainstem contains the essential neural circuitry for eliciting 
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visceral SND responses to hyperthermia (Kenney et al., 2000).  Yet, despite the fact that 
hyperthermia is a potent activator of the sympathetic nervous system, brainstem neural circuits 
are critically involved in eliciting an SND response to hyperthermia, and the frequency and 
intensity of heat waves are on the rise (Barbieri et al., 2006, Brown et al., 2007, Conti et al., 
2007, Davis et al., 2003, Diaz et al., 2006, Empereur-Bissonnet et al., 2006, Garssen et al., 2005, 
Hajat et al., 2007, Keatinge and Donaldson, 2004, Michelozzi et al., 2005, Naughton et al., 2002, 
Sharma, 2005, Simon et al., 2005, Tan et al. 2007, Weisskopf et al., 2002), little is known about 
the brainstem sites involved in mediating visceral SND responses to heating.   
The rostral ventral lateral medulla (RVLM) is a brainstem region that plays a critical role 
in basal and reflex regulation of efferent sympathetic nerve outflow (Barman, 1990; Dampney, 
1994; Dampney et al., 2003; Loewy, 1990; Strack et al., 1989; Sun, 1995; Sun, 1996).   RVLM 
neurons project to sympathetic preganglionic neurons in the spinal cord (Barman, 1990; 
Dampney, 1994; Dampney et al., 2003; Loewy, 1990; Strack et al., 1989; Sun, 1995) and 
inactivation of RVLM neurons produced by discrete RVLM microinjections of the GABAA 
receptor agonist muscimol or the local anesthetic lidocaine substantially reduce basal levels of 
SND (Cao et al., 2004; Fontes et al., 2001; Horiuchi and Dampney, 1998; Schreihofer et al., 
2000).  In addition, RVLM neurons are integrally involved in mediating the sympathetic nervous 
system component of the baroreceptor reflex (Dampney et al., 2003; Guyenet, 2006) and are 
involved in cardiovascular and SND responses to several interventions.  For example, RVLM 
microinjection of kynurenic acid (ionotropic excitatory amino acid receptor antagonist) abolishes 
increases in arterial pressure produced by stimulation of sciatic nerve afferents (Kiely and 
Gordon, 1994), the arterial blood pressure and sympathoexcitatory responses evoked by 
activation of neurons in the dorsomedial hypothalamus are substantially reduced following 
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bilateral RVLM microinjections of muscimol (Fontes et al., 2001, Horiuchi et al., 2004), and the 
cardiovascular and SND responses to the cold pressor test are significantly attenuated by RVLM 
microinjection of ionotropic glutamate receptor antagonists (Nakamura et al., 2008).  Despite the 
prominent contribution of the RVLM to SND regulation and the profound influence of acute 
heating on sympathetic nerve outflow, the role of the RVLM in mediating SND responses to 
increased Tc remains virtually unexplored.  This is a significant omission for at least two 
reasons.  First, little information is known about central mechanisms mediating SND responses 
to hyperthermia despite the fact that heat illness/stroke is characterized by sympathetic nervous 
system dysregulation and cardiovascular alterations (Huang et al., 2005, Kregel and Gisolfi, 
1989, Kregel et al., 1988).  Second, SND and cardiovascular responses to acute heating are 
altered in aged compared with young subjects (Kenney and Fels, 2002; Kenney and Fels, 2003, 
Minson et al., 1998), yet mechanisms contributing to age-related alterations in SND regulation to 
heating remain unexplored.  Establishing a role for the RVLM in mediating SND responses to 
heating in young rats may provide the experimental foundation for determining mechanisms 
mediating altered SND regulation to acute heat stress in aged rats.   
 Aging is associated with a number of alterations in SNS function and regulation, 
independent of the development of clinical disease (Seals and Esler, 2000).  Resting levels of 
muscle SND increase with age in healthy, normotensive adults (Dinenno et al., 1999, Jones et al., 
1997, Ng et al., 1993), whereas skin SND is reduced in aged compared with middle aged and 
young human subjects.  Importantly, recent studies by Kenney and Fels (Kenney and Fels, 2003; 
Kenney and Fels, 2002) have demonstrated that the responsiveness of sympathetic neural circuits 
to increases in core body temperature are altered with aging.  While hyperthermia produces 
progressive and significant increases in SND and changes the SND bursting pattern in young 
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rats, a similar response is not observed in aged rats.  The mechanisms underlying these age-
related alterations and the role of the RVLM remain unexplored.  This is especially important                   
Figure 1-7 Advancing age alters SND responses to acute heat stress 
 
 
 
 
 
 
 
 
Figure 1-8 SND pattern transformation is attenuated in aged (bottom) compared to young 
(top) 
 
 
 
 
 
 
 
 
when considering that excess mortality from hyperthermia and cardiovascular disease occur in 
aged humans during heat waves (Bouchama et al., 2007, Coris et al., 2004, Rey et al., 2007, 
Sharma, 2005; Sharma, 2007).  The fact that sympathetic nerves in young and aged humans and 
young and aged rats are spontaneously active and characterized by synchronized discharge bursts 
provides compelling rationale for using rodents in studies designed to determine central 
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mechanisms regulating SND in humans.  Therefore, as severe heat waves are on the rise and the 
proportion of aged persons is steadily increasing (globally it is estimated that the number of older 
persons (60+) will nearly triple by 2050 (United Nations, 2004) and there will be 2 elderly 
persons for every child), the motivation for determining brainstem mechanisms mediating SND 
responses, or lack thereof, to hyperthermia in young and aged rats is encouraged by the 
possibility of extrapolating these findings to understanding SND responses in humans.   
In the present study we tested the hypothesis that inhibition of RVLM synaptic activation 
at peak hyperthermia would markedly affect heating-induced visceral sympathoexcitation in 
anesthetized rats.  The effect of bilateral inhibition of RVLM synaptic activation produced by 
muscimol (GABAA receptor agonist) microinjections on the level of renal and splenic SND was 
determined after increasing Tc to 41.5°C.  Additional experiments were completed to determine 
the effect on SND of interrupting both synaptic and axonal transmission in the RVLM by 
bilateral microinjections of lidocaine (sodium channel blocker) at a Tc of 41.5°C.   
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Methods 
General Procedures 
 The Institutional Animal Care and Use Committee approved the experimental procedures 
and protocols used in the present study and all procedures were performed in accordance with 
the American Physiological Society’s guiding principles for research involving animals.  Male 
Sprague-Dawley rats (300-350 grams) were obtained from Harlan Sprague Dawley Inc. 
(Indianapolis, IN).  All rats were housed in 6 x 9 inch cages, received rat chow and water ad 
libitum, and were maintained in a 24°C room on a 12:12-h light-dark cycle.  Anesthesia was 
induced by isoflurane (3%) and maintained during surgical procedures using isoflurane (1.5%-
2.5%), α-chloralose (80 mg/kg, ip), and urethane (800 mg/kg, ip).  A catheter was placed in the 
femoral vein for the intravenous administration of maintenance doses of α-chloralose (35-45 
mg/kg/hr).  Maintenance doses of urethane (200 mg/kg every 4 hours) were administered 
intraperitoneally.  The trachea was cannulated with a polyethylene-240 catheter and rats were 
paralyzed with gallamine triethiodide (5-10 mg/kg iv, initial dose; 10-15 mg/kg/hr, maintenance 
dose) and artificially ventilated.  Femoral arterial pressure and heart rate (HR) were recorded 
using standard procedures.  Tc was measured with a thermistor probe inserted approximately 5-6 
cm into the colon and was kept at 38.0°C during surgery by a temperature-controlled table.   
Sinoaortic-denervation 
 To eliminate the influence of baroreceptor afferent feedback mechanisms that can alter 
SND responses of central origin, selected experiments were completed in sinoaortic-denervated 
(SAD) rats.  Bilateral denervation of the aortic arch was completed by sectioning the superior 
laryngeal nerve near its junction with the vagus nerve and removing the superior cervical 
ganglion.  Bilateral carotid sinus denervation was completed by removing the adventitia from the 
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area of the carotid sinus bifurcation. Sinoaortic-denervations were completed several hours 
before initiation of experimental protocols. The coherence function relating arterial pressure to 
SND was used to demonstrate the efficacy of the denervation procedure (Kenney et al., 1998).  
Coherence analysis provides a measure of the strength of linear correlation of two signals as a 
function of frequency.  The lack of coherence between arterial pressure and SND at the 
frequency of the HR demonstrated a complete sinoaortic denervation (Kocsis et al., 1990, Hirai 
et al., 1995).   
Sympathetic Nerve Recordings 
 Activity was recorded biphasically with a platinum bipolar electrode after capacity-
coupled preamplification (bandpass 30-3000 Hz) from the central end of cut or distally crushed 
renal and splenic sympathetic nerves.  The left renal and splenic nerves were isolated 
retroperitoneally and nerve-electrode preparations were covered with silicone gel to prevent 
exposure to room air.  The sympathetic nerve potentials were full wave rectified and integrated 
(time constant 10 ms) which produced a smooth tracing of the synchronized discharges.  Total 
power in splenic and renal SND was quantified as volts x seconds (V·s) (Kenney et al., 1998) 
and SND recordings were corrected for background noise after administration of the ganglionic 
blocker, chlorisondamine (5 mg/kg iv). 
RVLM Microinjections 
 Rats were placed in a stereotaxic apparatus, the incisor bar was set at -11 mm 
(Schreihofer et al., 2005), and the brainstem was exposed.  As described by Ito and Sved (Ito and 
Sved, 1997), target stereotaxic coordinates for the RVLM were 1.6-2.0 mm rostral to calamus 
scriptorius, 1.7-2.1 mm lateral from midline, and 2.6-3.2 mm below the dorsal surface of the 
brain.  RVLM microinjections were completed using multibarrel glass micropipettes (3 barrels, 
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outside tip diameter 40-70 μm) filled with appropriate drugs, with the pipette angled 20° rostrally 
(Schreihofer et al., 2005).  Microinjection volumes were determined with the aid of an operating 
microscope by measuring the displacement of the fluid meniscus in the micropipette barrel with 
respect to a horizontal grid.  In the majority of experiments the RVLM was functionally 
identified by completing glutamate (1 nmol) (Schreihofer et al., 2005) microinjections across a 
range of coordinates to locate the RVLM site producing the largest increase in mean arterial 
pressure (MAP).  RVLM sites producing glutamate-induced increases in MAP greater than 20 
mmHg were selected as experimental sites.  RVLM microinjection experiments were completed 
in 46 rats; glutamate mapping was completed in 24 of 25 baroreceptor-intact rats and 15 of 21 
SAD rats.   
Experimental Protocols 
 Before initiation of experimental protocols, anesthetized rats were allowed to stabilize for 
60 min.  At the end of this control period, Tc was increased at a rate of approximately 0.1°C/min 
from 38°C to 41.5°C using a heat lamp.  End-tidal CO2 was measured using a micro-capnometer 
(Columbus Instruments) and was maintained between 4.0% and 4.5% during experimental 
interventions by adjusting the frequency of ventilation during hyperthermia (control ventilatory 
rate, ~80-90 strokes/min; 41.5°C ventilatory rate, ~110-120 strokes/min).  Five experimental 
protocols were completed.  Microinjectate volume was 100 nl for each injection.  1) To 
determine the role of RVLM synaptic activation in sustaining visceral sympathoexcitation to 
hyperthermia, bilateral RVLM microinjections of muscimol were administered at a Tc of 41.5°C 
in baroreceptor intact (400 pmol, n=5; 800 pmol, n=3) and SAD (400 pmol, n=6; 800 pmol, n=4) 
rats.    2)  To determine the effect of interrupting both synaptic and axonal transmission in the 
RVLM on SND activation to acute heating, bilateral RVLM microinjections of lidocaine (40 
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nmol) were completed at a Tc of 41.5°C in baroreceptor-intact (n=4) and SAD (n=5) rats.  3) 
Volume control experiments were completed by determining SND responses to bilateral 
microinjections of saline (100 nl) after Tc had been increased to 41.5°C in baroreceptor-intact 
(n=6) and SAD (n=4) rats.  4) Anatomical control experiments (n=5) were completed by 
determining SND responses to bilateral microinjections of muscimol and lidocaine (same doses 
as above) after Tc had been increased to 41.5°C into sites that failed to increase MAP in response 
to glutamate microinjections.  Histological analysis revealed that anatomical control sites were 
typically dorsal or rostral to identified RVLM sites.  5)  Temperature control experiments were 
completed by determining SND responses to bilateral microinjections of muscimol and lidocaine 
(same doses as above) at a Tc of 38.0°C (intact, n=9; SAD, n=5).  Data included in the 
manuscript (MAP, HR, renal and splenic SND) were obtained at the following experimental 
times: 1) during the control period prior to initiation of heating, 2) at 0.5°C or 1.0°C increments 
as Tc was increased from 38°C to 41.5°C, and 3) each minute for three minutes after RVLM 
microinjections at 41.5°C.  Data from temperature control experiments were obtained each 
minute for three minutes after RVLM microinjections at 38°C. 
Brain Histology 
 At the end of each experiment, rats received an overdose of methohexital sodium (150 
mg/kg, iv).   Brains were removed and flash frozen in liquid nitrogen.  Brains were frozen 
sectioned at 25 µm in the coronal plane using a cryostat and mounted on slides in serial 
sequence.  The center of the injection site (as referenced to the tip of the micropipette) was 
localized by observing discrete clusters of latex microspheres.  Microspheres could be observed 
in brightfield or epifluoresence (rhodamine filter cube: BP 515-560 excitation filter).   
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Data and Statistical Analysis 
Values are means ± SE.  Control values of SND were considered as 0% and renal and 
splenic SND data are expressed as percentage change from baseline.  SND, MAP and HR 
responses were analyzed using analysis of variance techniques with a repeated-measures design 
followed by Bonferroni post hoc tests. The overall level of statistical significance was p<0.05. 
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Results 
Figure 1-9 shows the effect of a unilateral RVLM glutamate microinjection on arterial 
blood pressure from a representative experiment.  The average increase in MAP to glutamate 
microinjections in right and left RVLM sites was similar within groups (baroreceptor-intact, 
right vs. left; SAD, right vs. left) (Figure 1-10), but was higher in SAD compared with 
baroreceptor-intact rats (Figure 1B).  Injection sites were verified by observing discrete clusters 
of latex microspheres that were injected from the micropipette.  Figure 1C shows a 
representative example of brainstem histology and the location of microspheres in the RVLM.  
Figure 1D shows the distribution of RVLM injection sites mapped on a standard coronal section 
from the atlas of Paxinos and Watson (Paxinos and Watson, 2005) at the level 12.12 mm caudal 
to bregma.  For display purposes every injection site is not shown; however, the centers of 
visualized injection sites were all in the RVLM and located within 200 microns of the 
represented section. 
Figure 2 shows original tracings from a representative experiment of renal and splenic 
SND and arterial blood pressure recorded at control (38°C), during acute heating with Tc 
maintained at 41.5°C, during and immediately after bilateral RVLM muscimol (400 pmol) 
microinjections, 3 min after completion of RVLM microinjections, and following ganglionic 
blockade.  SND (renal and splenic) recorded at 41.5°C was increased from levels recorded at 
38°C.  RVLM muscimol microinjections at 41.5°C produced immediate reductions in renal and 
splenic SND to levels below control and substantially reduced arterial blood pressure.   
Tc was increased from 38°C to 41.5°C in 35 min and maintained at this level for 3 min 
after RVLM microinjections (Figure 3). Because similar results were observed between 
baroreceptor-intact and SAD rats (changes in renal and splenic SND recorded 3 min after RVLM 
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microinjections of muscimol and lidocaine at 41.5°C in baroreceptor-intact and SAD rats are 
shown in Table 1), data from these groups were combined for presentation.  The top panels of 
Figure 3 show summarized renal (left) and splenic (right) SND data from RVLM microinjections 
completed during acute heating.  Renal (left) and splenic (right) SND were significantly 
increased from preheating control levels at 41.5°C.  RVLM muscimol (400, n=11 pmol; 800, 
n=7 pmol) and lidocaine (40 nmol, n=9) microinjections at 41.5°C abruptly and significantly 
reduced renal and splenic SND from peak sympathoexcitatory levels for at least 3 min following 
the respective microinjections.  Levels of SND recorded after RVLM microinjections did not 
differ between the doses of muscimol (400 and 800 pmol) or between muscimol (both doses) and 
lidocaine.  Renal and splenic SND remained unchanged in response to RVLM saline (n=10) 
microinjections at 41.5°C. 
The bottom panels of Figure 3 show summarized MAP (left) and HR (right) data from 
RVLM microinjections completed during acute heating.  MAP was not substantially changed 
from control levels (38°C) during progressive hyperthermia.  RVLM muscimol (400 and 800 
pmol) and lidocaine (40 nmol) microinjections at 41.5°C abruptly and significantly reduced 
MAP.  Levels of MAP recorded after RVLM microinjections did not differ between the doses of 
muscimol (400 and 800 pmol) or between muscimol (both doses) and lidocaine.  MAP remained 
unchanged in response to RVLM saline microinjections at 41.5°C.  HR was significantly 
increased from control levels during acute heating and bilateral RVLM microinjections of 
muscimol (400 and 800 pmol) and lidocaine (40 nmol) at 41.5°C produced significant but 
modest reductions in HR from peak heating levels.  HR remained unchanged from peak heating 
levels in response to RVLM saline microinjections at 41.5°C. 
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Microinjection of muscimol with Tc maintained at 41.5°C into sites identified to be 
functionally outside the RVLM (non-RVLM, n=5) did not alter the level of SND (renal and 
splenic combined for presentation) (Figure 4), whereas RVLM muscimol microinjection at 
41.5°C (represented by 400 pmol data) significantly reduced SND (Figure 4). 
Figure 5 shows summarized renal (left) and splenic (right) SND data from RVLM 
microinjection experiments completed at 41.5°C (same data as shown in Figure 3) and RVLM 
microinjection experiments completed at 38°C.  RVLM muscimol (400 pmol, n=5; 800 pmol, 
n=4) and lidocaine (40 nmol, n=5) microinjections at 38°C significantly reduced renal and 
splenic SND below control levels.  As shown previously, RVLM muscimol and lidocaine 
microinjections at 41.5°C significantly reduced renal and splenic SND from peak heating-
induced levels, however, the percent reduction in SND from control levels following RVLM 
microinjections at 41.5°C was less than that observed following RVLM microinjections at 38°C. 
Figure 6 shows summarized absolute levels (measured in volt•seconds, V•s) of renal (top) 
and splenic (bottom) SND from RVLM muscimol (400 and 800 pmol) and lidocaine (40 nmol) 
microinjections completed at 38°C (basal, left) and at 41.5°C (hyperthermia, right).  SND data 
from RVLM muscimol (both doses) and lidocaine microinjections were combined for 
presentation.  Control levels of renal and splenic SND were similar in each group.  The amount 
of activity inhibited in response to RVLM muscimol and lidocaine microinjections was 
significantly greater during hyperthermia than normothermia for both renal SND (41.5°C, 16.8±1 
V•s; 38°C, 7.9±1 V•s;) and splenic SND (41.5°C, 14.8±2 V•s; 38°C, 8.5±1 V•s;).   
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Discussion 
 The current study revealed three new findings.  First, bilateral inhibition of RVLM 
synaptic activation produced by muscimol microinjections at 41.5°C resulted in immediate and 
significant reductions in heating-induced renal and splenic sympathoexcitatory responses.  
Second, interruption of RVLM synaptic activation and axonal transmission by bilateral 
microinjections of lidocaine at 41.5°C produced significant reductions in hyperthermia-induced 
sympathetic activation to levels comparable to those produced by RVLM muscimol 
microinjections.  Third, the total amount of visceral SND inhibited by RVLM muscimol and 
lidocaine microinjections was significantly greater during hyperthermia (41.5°C) than 
normothermia (38°C).         
 Determining a role for the RVLM in sympathetic nerve activation at peak hyperthermia 
required the completion of and interpretation of data from several experimental protocols.  First, 
the RVLM was successfully targeted as demonstrated by completion of functional mapping 
procedures and histological analysis of RVLM anatomical sites. Consistent with previous 
findings by Schreihofer et al. (Schreihofer et al., 2005), RVLM glutamate microinjections 
significantly increased MAP in baroreceptor-intact and SAD rats, with pressor responses higher 
in SAD rats.  Histological examination confirmed that the centers of the microinjection sites 
were contained in the rostrocaudal extent of the RVLM as described in the atlas of Paxinos and 
Watson (Paxinos and Watson, 2005).  Second, muscimol microinjections at 41.5°C into sites that 
failed to increase MAP in response to glutamate microinjections had no effect on SND, 
demonstrating anatomical specificity of RVLM sites.  Third, RVLM saline microinjections at 
41.5°C had no effect on the level of SND, indicating that decreases in SND to RVLM muscimol 
and lidocaine microinjections during hyperthermia were not mediated by vehicle or volume 
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effects.  Fourth, RVLM muscimol and lidocaine microinjections produced similar reductions in 
SND in baroreceptor-intact and SAD rats, indicating that the arterial baroreflex did not play a 
key role in mediating the observed responses. 
 RVLM muscimol and lidocaine microinjections at 41.5°C reduced SND nearly 70% from 
peak heating-induced sympathoexcitation to levels ranging from slightly above to approximately 
30% below preheating control values (Figure 5).  Consistent with previous findings (Cao et al., 
2004, Fontes et al., 2001, Horiuchi and Dampney, 1998, Schreihofer et al., 2000), RVLM 
muscimol and lidocaine microinjections at normothermia (38°C) reduced SND 60-70% below 
control values, suggesting at first glance that a similar amount of nerve activity was inhibited in 
response to RVLM microinjections completed at 38°C and 41.5°C.  However, SND responses 
must be interpreted with caution when percent changes are calculated from markedly different 
levels, as is the case with SND recorded at 38°C and 41.5°C.  Therefore, it was important to 
consider the effect of RVLM microinjections at 38°C and 41.5°C on the absolute level 
(measured as V•s) of renal and splenic SND.  The total amount of nerve activity inhibited by 
RVLM muscimol and lidocaine microinjections was significantly greater during hyperthermia 
than normothermia for both renal and splenic SND (Figure 6), indicating that the functional 
integrity of RVLM neural circuits is required for sustaining a substantial component of visceral 
sympathetic activation recorded at peak hyperthermia.      
 Although RVLM muscimol and lidocaine microinjections at 41.5°C substantially reduced 
SND to below preheating control levels, the absolute level of activity remaining after RVLM 
microinjections was higher at 41.5°C than 38°C.  Several possibilities can be considered to 
explain temperature-related differences in the level of SND remaining after RVLM muscimol 
and lidocaine microinjections.  First, activation of RVLM sympathetic neural circuits during 
20 
 
acute heating may be so profound that RVLM muscimol microinjections at 41.5°C did not 
sufficiently block synaptic activation.  We considered this possibility and completed RVLM 
muscimol microinjections at two different doses (400 and 800 pmol), each of which produced 
similar reductions of SND.  If the attenuated inhibition of SND after RVLM muscimol 
microinjections at 41.5°C was the result of insufficient block of RVLM synaptic activation, then 
it would be expected that dose-related differences in the level of inhibition would be evident, 
however this was not the case.  Second, it may be that fibers of passage within the RVLM 
substantially contribute to sympathetic activation during acute heating.  This is likely not the 
case, however, as similar levels of SND were recorded at 41.5°C after RVLM muscimol (both 
doses) and lidocaine microinjections.  Third, in response to acute heating spinal neural systems 
can activate the sympathetic nervous system in the absence of supraspinal neural circuits 
(Kenney et al., 2000), suggesting that spinal sympathetic neural circuits may contribute to the 
higher level of SND remaining after RVLM muscimol and lidocaine microinjections in heated 
compared to nonheated rats.  Fourth, visceral sympathoexcitation to acute heating may result 
from activation of neural circuits in the RVLM as well as in other brainstem regions.  Consistent 
with this notion, the cell bodies of brainstem presympathetic neurons whose axons project to 
sympathetic preganglionic neurons in the spinal cord are located not only in the RVLM but also 
in the rostral ventromedial medulla, midline medulla, and the A5 cell group in the pons (Strack et 
al., 1989).  Additionally, enhanced coupling between respiratory and sympathetic nerve-related 
central circuits may contribute to heat-induced visceral sympathoexcitation as hyperthermia 
enhances the frequency-domain coupling between SND and phrenic nerve bursts (Kenney et al., 
1998).  Fifth, it may be that RVLM neural circuits are not prominently activated during acute 
heating; rather, activation of neural circuits in other brainstem regions may increase the 
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effectiveness of the basal excitatory drive arising from the RVLM, thereby enabling a modestly 
activated RVLM to drive a larger population of preganglionic sympathetic neurons.   
 Because heating-induced sympathoexcitatory responses play a critical role in mediating 
cardiovascular responses to increased Tc (Kenney et al., 1998, Kregel and Gisolfi, 1989, Kregel 
et al., 1988), it was expected that MAP would be altered following inactivation of the RVLM.  
RVLM muscimol and lidocaine microinjections at 41.5°C produced marked reductions in MAP 
to near or below 50 mmHg.  Because of the profound hypotension produced by RVLM 
inhibition, we did not attempt to determine if RVLM muscimol and lidocaine pretreatment would 
prevent sympathoexcitatory responses to progressive hyperthermia.  HR was significantly 
increased during hyperthermia; however, bilateral inactivation of RVLM neural circuits at 
41.5°C resulted in modest reductions in HR from peak heating-induced levels.     
 Determining the role of RVLM neural circuits in mediating visceral sympathoexcitation 
to acute hyperthermia is important for at least two reasons.  First, although it is well established 
that the RVLM contains a diverse array of neurotransmitter and receptor systems (Sun, 1995) 
and that regulation of basal SND involves a complex balance between RVLM excitatory and 
inhibitory systems (Dampney, 1994, Dampney et al., 2003, Horiuchi et al., 2004, Ito and Sved, 
1997, Kiely and Gordon, 1994, Sakima et al., 2000), much less information is known about 
RVLM regulatory mechanisms mediating SND responses to acute physiological stress.  Because 
heating provides a potent stimulus to visceral SND and because a substantial amount of 
sympathetic activation during peak-hyperthermia is dependent on intact RVLM neural circuits, 
the current findings provide foundational information for designing studies to determine RVLM 
mechanisms mediating sympathetic activation to acute stress.  For example, it may be that SND 
activation to heat stress is mediated by multiple receptor systems that interact in a dynamic and 
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coordinated manner to produce profound enhancement of RVLM synaptic excitation and 
attenuation of synaptic inhibition.  Second, the results of recent studies by Kenney and Fels 
(Kenney and Fels, 2002, Kenney and Fels, 2003) demonstrate attenuated SND activation to 
heating in aged rats.  However, mechanisms contributing to age-related alterations in SND 
regulation to heating remain unexplored.  It may be that aging modifies regulation of the RVLM 
in response to acute heating, for example, aging may shift the balance of RVLM regulation 
during heating to a state characterized by enhanced synaptic inhibition and reduced synaptic 
excitation. 
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Figure 1-9 Tracing of arterial blood pressure (BP) from a representative experiment 
completed before and after unilateral microinjection of glutamate into the RVLM.  
Horizontal calibration is 2 s.    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-10 Average increases in MAP to glutamate microinjections in right and left 
RVLM sites in baroreceptor-intact (left) and sinoaortic-denervated (SAD) (right) rats.   
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Figure 1-11 A. Representative histological coronal section of the medulla containing 
fluorescent microspheres (arrow) marking an RVLM microinjection site.  B. Filled circles 
indicate the distribution of histologically verified RVLM microinjection sites mapped on a 
standard coronal section (Bregma -12.12 mm) from Paxinos and Watson. 
 
A.                           B. 
 
 
 
 
 
 
 
 
 
 
Figure 1-12 Traces of integrated renal and splenic SND bursts and arterial blood pressure 
(BP) recorded at control (38°C), during acute heating with Tc maintained at 41.5°C, during 
and immediately after bilateral RVLM muscimol microinjections, 3 min post-
microinjection, and following ganglionic blockade.  Horizontal calibration is 8 s. 
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Figure 1-13 Changes in renal SND, splenic SND, MAP, and HR during increases in Tc 
from 38° to 41.5°C and for 3 min following RVLM microinjections (designated by arrow) 
of muscimol (400 pmol and 800 pmol), lidocaine (40 nmol), or saline at 41.5°C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Muscimol (400 and 800 pmol), lidocaine (40 nmol), and saline (100 nl) significantly different from control 
(38°C) at peak hyperthermia (41.5°C).  **Muscimol (400 and 800 pmol) and lidocaine (40 nmol) significantly 
different from peak-heating levels at 1, 2 and 3 min post-microinjection. 
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Figure 1-14 Changes in renal and splenic SND during increases in Tc from 38° to 41.5°C 
and for 3 min following muscimol microinjections (Tc maintained at 41.5°C) in RVLM 
sites and in sites identified to be functionally outside the RVLM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*RVLM and non-RVLM microinjections significantly different from control (38°C).   ** RVLM muscimol 
significantly different from non-RVLM muscimol at 1, 2 and 3 min post-microinjection. 
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Figure 1-15 Changes in renal and splenic SND from RVLM muscimol (400 and 800 pmol) 
and lidocaine (40 nmol) microinjection experiments completed at 41.5°C and RVLM 
muscimol (both doses) and lidocaine microinjection experiments completed at 38°C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*RVLM muscimol (400 and 800 pmol) and lidocaine (40 nmol) microinjections at 38°C significantly different 
from control at 1, 2, and 3 min post-microinjection.  **RVLM muscimol (400 and 800 pmol) and lidocaine 
microinjections (40 nmol) significantly different from peak-heating levels (41.5°C) at 1, 2 and 3 min post-
microinjection. 
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Figure 1-16 Changes in the absolute level of renal and splenic SND (recorded as 
volt•seconds) following RVLM microinjections of muscimol (400 and 800 pmol) and 
lidocaine (40 nmol) from experiments with Tc maintained at 38°C compared to 
experiments in which Tc was increased to 41.5°C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Change in SND (V•s) significantly different following RVLM microinjection of muscimol (400 and 800 pmol) 
and lidocaine at 41.5°C compared to RVLM microinjection of muscimol (both doses) and lidocaine at 38°C 
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Table 1-1 Changes in renal and splenic SND 3 minutes after RVLM microinjections of 
muscimol (400 and 800 pmol) and lidocaine (40 nmol) at 41.5°C in baroreceptor-intact and 
sinoaortic-denervated (SAD) rats. 
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